更紧凑的生命科学资讯库。
先搜索,再按来源或主题继续收窄。
Thermo Fisher将收购Clario以提升临床洞察力并加速创新——医疗科技报告。
Thermo Fisher to Purchase Clario to Enhance Clinical Insights and Accelerate Innovation The Healthcare Technology Report.
Thermo Fisher Scientific收购Clario,深化临床洞察力——MedTech Intelligence报道
Thermo Fisher Scientific to Acquire Clario to Provide Deeper Clinical Insights MedTech Intelligence
Thermo Fisher以90亿美元收购临床试验技术公司Clario,扩充业务版图——Fierce Biotech报道
Thermo Fisher adds clinical trial tech outfit Clario to goodie bag in $9B deal Fierce Biotech
赛默飞世尔以88亿美元收购Clario——临床试验领域动态
Thermo Fisher to buy Clario for $8.8bn Clinical Trials Arena
赛默飞世尔拟以高达94亿美元收购临床服务提供商Clario——路透社报道
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion Reuters
Thermo Fisher以89亿美元收购临床试验数据公司Clario - MedTech Dive报道
Thermo Fisher to acquire clinical trial data firm Clario for $8.9B MedTech Dive
Latham & Watkins 就 Clario 以 88.75 亿美元出售给 Thermo Fisher Scientific 提供法律咨询 - Latham & Watkins LLP
Latham & Watkins Advises Clario in US$8.875 Billion Sale to Thermo Fisher Scientific Latham & Watkins LLP
Thermo Fisher Scientific将收购Clario Holdings, Inc.,助力制药与生物技术客户通过深化临床洞察加速创新 - 商业通讯
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights Business Wire
赛默飞世尔科技同意以88.8亿美元收购Clario控股公司——《华尔街日报》
Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion The Wall Street Journal
据金融时报报道,Thermo Fisher接近以100亿美元收购Clario——路透社消息
Thermo Fisher nears $10 billion takeover of Clario, FT reports Reuters
把品牌目录放在视野里,但不抢主叙事
把工具、CRO、生物制药和器械公司做成滚动资源带,作为资讯流下方的辅助索引。
查看关于页